The relationship of antiphospholipid antibodies to thromboembolic events in pediatric patients with Systemic Lupus Erythematosus: A cross-sectional study

Pediatric Research

Volumn 44, Issue 3, 1998, Pages 351-356

  Berube, Caroline ^a   Mitchell, Lesley ^a   Silverman, Earl ^c   David, Michele ^b   Cyr, Claire Saint ^b   Laxer, Ronald ^c   Adams, Margaret ^a   Vegh, Patsy ^a   Andrew, Maureen ^a  

^a HAMILTON HEALTH SCIENCES   (Canada)

^b UNIVERSITY OF MONTREAL   (Canada)

^c HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOLIPIN ANTIBODY; LUPUS ANTICOAGULANT; PHOSPHOLIPID ANTIBODY;

ADOLESCENT; ADULT; ANTIBODY DETECTION; ARTICLE; CHILD; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; HUMAN; IMMUNOPATHOGENESIS; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SCHOOL CHILD; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOEMBOLISM;

EID: 0031820118     PISSN: 00313998     EISSN: None     Source Type: Journal    
DOI: 10.1203/00006450-199809000-00014     Document Type: Article

References (37)

1. Horbach DA, van Dort E, Donders RC, Derksen RH, de Groot PO 1996 Lupus anticoagulant is the strongest risk factor for both venous and arterial thrombosis in patients with systemic lupus erythematosus. Comparison between different assays for the detection of antiphospholipid antibodies. Thromb Haemost 76:916-924
2. Puurunen M, Vaarala O, Julkunen H, Aho K, Palosuo T 1996 Antibodies to phospholipid-binding plasma proteins and occurrence of thrombosis in patients with systemic lupus erythematosus. Clin Immunol Immunopathol 80:16-22
3. Alarcon-Segovia D, Deleze M, Oria CV, Sanchez-Guerrero J. Gomez-Pacheco L, Cabiedes J, Fernandez L, Ponce De Leon S 1989 Antiphospholipid antibodies and the antiphospholipid syndrome in systemic lupus erythematosus: a prospective analysis of 500 consecutive patients. Medicine 68:353-365
4. Long AA, Ginsberg JS, Brill-Edwards P, Johnston M, Turner C, Denburg JA, Bensen WG, Cividino A, Andrew M, Hirsh J 1991 The relationship of antiphospholipid antibodies to thromboembolic disease in systemic lupus erythematosus: a cross-sectional study. Thromb Haemost 66:520-524
5. Love PE, Santoro SA 1990 Antiphospholipid antibodies: anticardiolipin and the lupus anticoagulant in systemic lupus erythematosus (SLE) and in non-SLE disorders. Ann Intern Med 112:682-698
6. Harris E, Boey M, Mackworth-Young C, Gharavi AE, Patel BM, Loizou S, Hughes GRV 1983 Anticardiolipin antibodies: detection by radioimmunoassay and association with thrombosis in systemic lupus erythematosus. Lancet 2:1211-1214
7. Roubey RAS 1994 Autoantibodies to phospholipid-binding plasma proteins: a new view of lupus anticoagulants and other "antiphospholipid" autoantibodies. Blood 84:2854-2867
8. Bevers EM, Galli M, Barbui T, Comfurius P, Zwaal RFA 1991 Lupus anticoagulant IgG's (LA) are not directed to phospholipids only, but to a complex of lipid-bound human prothrombin. Thromb Haemost 66:629-632
9. 2glycoprotein I (apolipoprotein H). Proc Natl Acad Sci USA 87:4120-4124
10. Bevers EM, Galli M 1990 Beta 2-glycoprotein I for binding of anticardiolipin antibodies to cardiolipin. Lancet 336:952-953
11. St Clair W, Jones B, Rogers JS, Crouch M, Hrabovsky E 1981 Deep venous thrombosis and a circulating anticoagulant in systemic lupus erythematosus. Am J Dis Child 135:230-232
12. Khamashta MA, Hughes GR 1994 Antiphospholipid antibodies. A marker for thrombosis and recurrent abortion. Clin Rev Allergy 12:287-296
13. Asherson RA, Hughes GR 1992 Vascular disease and thrombosis: relationship to the antiphospholipid antibodies. Contrib Nephrol 99:17-25
14. Ishii Y, Nagasawa K, Mayumi T, Niho Y 1990 Clinical importance of persistence of anticardiolipin antibodies in systemic lupus erythematosus. Ann Rheum Dis 49:387-390
15. Feinstein D 1985 Lupus anticoagulant, thrombosis and fetal loss. N Engl J Med 313:1348-1350
16. Harris E, Chan J, Asherson R, Aber, V, Gharavi AE, Hughes GRV 1986 Thrombosis, recurrent fetal loss and thrombocytopenia. Predictive value of the anticardiolipin antibody test. Arch Intern Med 146:2153-2156
17. Dungan DD, Jay MS 1992 Stroke in an early adolescent with systemic lupus erythematosus and coexistent antiphospholipid antibodies. Pediatrics 90:96-99
18. Pelkonen P, Simell O, Rasi V, Vaarala O 1988 Venous thrombosis associated with lupus anticoagulant and anticardiolipin antibodies. Acta Pediatr Scand 77:767-772
19. Appan S, Boey ML, Lim KW 1987 Multiple thrombosis in systemic lupus erythematosus. Arch Dis Child 62:739-741
20. Bernstein ML, Salunsinsky-Sternbach M, Bellefleur M, Esseltine DW 1984 Thrombotic and hemorrhagic complications in children with lupus anticoagulant. Am J Dis Child 138:1132-1135
21. Olive D, Brocard O, Labrude P, Alexandre P 1979 Lupus Erythemateux dissemine revele par des thrombophlebites des membres inferieurs. Arch Fr Pediatr 36:807-811
22. Ostuni PA, Lazzarin P, Pengo V, Ruffatti A, Schiavon F, Gambari P 1990 Renal artery thrombosis and hypertension in a 13 year old girl with antiphospholipid syndrome. Ann Rheum Dis 49:184-187
23. Kwong T, Leonidas JC, Ilowite NT 1994 Asymptomatic superior vena cava thrombosis and pulmonary embolism in an adolescent with SLE and antiphospholipid antibodies. Clin Exp Rheum 12:215-217
24. Rider LG, Clarke WR, Rutledge J 1992 Pulmonary hypertension in a seventeen-year-old boy. J Pediatr 120:149-159
25. Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfleld NF, Schaller JG, Talal N, Winchester RJ 1982 The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 25:1271-1277
26. Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH 1992 Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum 35:630-640
27. Andrew MA, Vegh PA, Johnston M, Bowker J, Ofuso F, Mitchell L 1992 Maturation of the hemostatic system during childhood. Blood 80:1998-2005
28. Proctor R, Rapaport S 1961 The partial thromboplastin time with kaolin. Am J Clin Pathol 36:212-219
29. Alving BM, Baldwin PE, Richards RL, Jackson BJ 1985 The dilute phospholipid APTT: a sensitive assay for verification of lupus anticoagulants. Thromb Haemost 54:709-714
30. Schleider M, Nachman R, Jaffe E, Coleman M 1976 A clinical study of the lupus anticoagulant. Blood 48:499-509
31. Thiagarajan P, Pengo, V, Shapiro S 1986 The use of dilute Russell Viper Venom time for the diagnosis of lupus anticoagulants. Blood 68:869-874
32. Ginsberg JS, Brill-Edwards P, Johnston M, Denburg JA, Andrew M, Burrows RF, Bensen W, Cividino A, Long AA 1992 Relationship of antiphospholipid antibodies to pregnancy loss in patients with systemic lupus erythematosus: a cross-sectional study. Blood 80:975-980
33. Ginsberg JS, Demers C, Brill-Edwards P, Johnston M, Bona R, Burrows RF, Weitz J, Denburg JA 1993 Increased thrombin generation and activity in patients with systemic lupus erythematosus and anticardiolipin antibodies: evidence for a prothrombotic state. Blood 81:2958-2963
34. Ginsberg JS, Wells PS, Brill-Edwards P, Donovan D, Moffat K, Johnston M, Stevens P, Hirsh J 1995 Antiphospholipid antibodies and venous thromboembolism. Blood 86:3685-3691
35. Brandt JT, Triplett DA, Alving B, Scharrer I 1995 Criteria for the diagnosis of lupus anticoagulants: an update. Thromb Haemost 74:1185-1190
36. Ravelli A, Caporali R, Di Fuccia G, Zonta L, Montecucco C, Martini A 1994 Anticardiolipin antibodies in pediatric systemic lupus erythematosus. Arch Pediatr Adolesc Med 148:398-402
37. Shergy W, Kredich D, Pisetsky D 1988 The relationship of anticardiolipin antibodies to disease manifestations in pediatric systemic lupus erythematosus. J Rheumatol 15:1389-1394